Eiger BioPharmaceuticals Inc (EIGRQ)

[Marilynt]

CLDN - Let's not forget the Merger...

Eiger BioPharma eyes the shell of Celladon to back its way onto Wall Street

November 19, 2015 | By Damian Garde

Privately held Eiger BioPharmaceuticals has signed a deal to merge with failed gene therapy biotech Celladon ($CLDN), looking to make its way onto Wall Street and press forward with a handful of treatments for rare disease.

Under the deal, Eiger's shareholders would take control of Celladon, a once-promising company that plunged into penny-stock territory after the failure of its cardiac treatment. Eiger's backers have put an initial $6 million into the company to support its plan, and they've promised another $33.5 million if and when the merger closes, which the company expects to happen in the first half of next year.

If Celladon shareholders sign off on the deal, the combined company will do business under Eiger's name and move forward with more than $60 million in cash, the company said.

http://www.fiercebiotech.com/story/eiger-biopharma-eyes-shell-celladon-back-its-way-wall-street/2015-11-19